Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Spot budgeting mistakes that inflate spending and apply practical methods to trim costs, save more, and stabilize your monthly bills. Act now.
13,590 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Nasdaq slides as Meta and Micron weigh on tech leadership. This deep dive keeps you informed with market moves, trend...
Investors are recalibrating after airports report faster screening and shorter lines, sparking a mixed revaluation of...
As 2026 nears, one stock stands out for investors: the company that’s about to launch the year’s first blockbuster st...
The Nasdaq Composite extended gains as bulls maintain control amid stronger tech deal activity, improving chip profit...
Upstart’s growth engine faces higher costs that squeeze margins, triggering a drop in price even when revenue beats. ...
Boomers face tighter retirement math as Social Security loses buying power and markets test savings. This report outl...
NVIDIA's Huang warns of a potential AI leadership shift as Huawei accelerates its chip ambitions. Markets react as in...
BBB Foods reports Q1 2026 results with modest revenue growth and steadier margins. This review translates the transcr...
Investors are watching alarm.com with a focus on how 2026 earnings will unfold. This guide explains the key drivers, ...
Alpha (AMR) just reported Q1 2026 results, raising questions about growth and margins. This analysis breaks down the ...
Rocket Lab rockets higher after a record Q1 FY2026 showing strong revenue and a bloated backlog, signaling momentum f...